Avanzanite Bioscience
Wendy Huisman is currently the Head of Patient Safety at Avanzanite Bioscience since August 2022. She also holds positions as EU Qualified Person for Pharmacovigilance (EU QPPV) and Senior Pharmacovigilance Consultant at Deciphera Pharmaceuticals, as well as a Course director, trainer and program committee member at DIA. Wendy is a Program Committee Member of the MSc Pharmacovigilance at the University of Hertfordshire and an Advisory Board Member at Pharmacovigilance Platform Netherlands (PPN). Previously, she has held roles as Deputy EU Qualified Person for Pharmacovigilance (QPPV) at Seagen, Chair of Pharmacovigilance Focus group at EUCOPE, and EU Qualified Person for Pharmacovigilance at Kiadis Pharma. Wendy has a PharmD in Pharmacy from Utrecht University and a Postgraduate Diploma in Drug Development Sciences from the University of Surrey.
This person is not in the org chart
This person is not in any teams
Avanzanite Bioscience
Founded by biopharmaceutical executives, Adam Plich and Anant Murthy, Avanzanite is on a mission to redefine the commercialization of orphan medicines to improve patient access across Europe and beyond. Derived from the word ‘Tanzanite’ – one of the rarest and most underappreciated gemstones on earth – Avanzanite was formed to capitalize on two primary objectives, one economic, and one humanitarian. The economic goal is to offer end-to-end commercialization and distribution partnerships with research-based biopharmaceutical originators to unlock the full value of their orphan medicines in European markets. This is the unique expertise and core competency of our team following decades of operating experience navigating this area. Equally important, our humanitarian goals stem from our commitment to enabling access to novel medicines for patients who suffer from orphan diseases regardless of where in Europe they live. Avanzanite Bioscience B.V. is a fully authorized distributor of medicinal products within the European Economic Area, Switzerland and the UK, with a Wholesale Distributor Authorization (WDA) issued by Farmatec in the Netherlands.